179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Pierre, C. ; Goter, T. ; Agar, C. ; Luzi, S. ; Lena, H. ; Guen, Y. Le ; Ricordel, C.

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S794-S795 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível